KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Accumulated Expenses: 2009-2024

Historic Accumulated Expenses for Exact Sciences (EXAS) over the last 16 years, with Dec 2024 value amounting to $328.3 million.

  • Exact Sciences' Accumulated Expenses rose 30.18% to $408.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $408.8 million, marking a year-over-year increase of 30.18%. This contributed to the annual value of $328.3 million for FY2024, which is 3.92% down from last year.
  • Latest data reveals that Exact Sciences reported Accumulated Expenses of $328.3 million as of FY2024, which was down 3.92% from $341.7 million recorded in FY2023.
  • Over the past 5 years, Exact Sciences' Accumulated Expenses peaked at $398.6 million during FY2021, and registered a low of $233.6 million during FY2020.
  • Moreover, its 3-year median value for Accumulated Expenses was $328.3 million (2024), whereas its average is $323.1 million.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first surged by 70.61% in 2021, then decreased by 24.92% in 2022.
  • Over the past 5 years, Exact Sciences' Accumulated Expenses (Yearly) stood at $233.6 million in 2020, then spiked by 70.61% to $398.6 million in 2021, then fell by 24.92% to $299.2 million in 2022, then grew by 14.19% to $341.7 million in 2023, then fell by 3.92% to $328.3 million in 2024.